Article
Lactated Ringer’s Administration Improved Outcomes Over Normal Saline Administration During Sickle Cell Vaso-Occlusive Episode
May 1, 2025
Clinical question: Is there a difference in the effectiveness of sickle cell vaso-occlusive episode treatment with lactated Ringer’s (LR) solution versus normal saline (NS)? Background: Initial...
Article
SGLT-2 inhibitors May Decrease Recurrent Gout Flares in Patients with Type 2 diabetes
May 1, 2024
Dr. Bernal Clinical question: Do SGLT-2 inhibitors decrease gout flares in patients with type 2 diabetes and a known history of gout? Background: Sodium–glucose cotransporter-2 inhibitors...
Article
Should You Feed Patients Admitted for IBD Flares?
January 3, 2023
Case: A 26-year-old woman with a history of poorly controlled Crohn’s Disease (CD) presents to the emergency department (ED) with complaints of progressively worsening diarrhea for the past two...
Article
The risk for intestinal necrosis with SPS is very low
August 1, 2022
Dr. Lippert Clinical question: What is the risk of intestinal necrosis with sodium polystyrene (SPS) for the treatment of hyperkalemia? Background: SPS is a medication that has been available...
![1]()
News
New data on rare myocarditis after COVID-19 vaccination
December 8, 2021
Most adolescents and young adults recover quickly from the rare complication of myocarditis following mRNA COVID-19 vaccination, a new study shows.
![1]()
News
No serious CV risks for elderly after Pfizer COVID-19 vaccine
December 2, 2021
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.
News
Even one vaccinated member can cut family’s COVID risk
October 14, 2021
Study findings may be particularly welcome in regions of the world where vaccination rates are very low, according to investigators.
News
No short-term death risk in elderly after COVID-19 vaccines
October 13, 2021
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
News
Clostridioides difficile: Two sets of guidelines disagree
July 8, 2021
Clinicians may find themselves trying to reconcile conflicts between the American College of Gastroenterology and Infectious Diseases Society of America guidelines.
